Hypothesizing that the previously reported elevated expression of TRPA1 in individuals suffering from Crohn’s disease might be due to epigenetic regulation, we used DNA from whole blood of Crohn patients and healthy participants to analyze the methylation status of individual CpG sites in the TRPA1 promoter with regard to pain sensitivity. This evidence concerns the gene TRPA1 and Crohn disease.